TipRanks
Go Ultimate55% OFF

AB Dynamics (6DY) AI Stock Analysis

0 Followers
DE:6DY

AB Dynamics

(Frankfurt:6DY)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Robust balance sheetConservative leverage and a strong equity base provide AB Dynamics with financial resilience as it manages uneven order timing. Improving returns on equity also indicate that capital is being deployed effectively, supporting continued investment in products, R&D and growth without excessive balance-sheet strain.
Negative Factors
Revenue and earnings contractionThe broad decline in revenue, operating profit and EPS shows that recent demand and delivery timing have materially reduced current earnings power. Continued weakness would limit operating leverage and make the company more reliant on a successful recovery in orders and execution.

AB Dynamics (6DY) vs. iShares MSCI Germany ETF (EWG)

-40%-30%-20%-10%0%10%20%DE:6DY-34.65%EWG+3.55%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 177.90M
Dividend Yield
1.13%
Average Volume (3M)
273
Price to Earnings (P/E)
-33.7
Beta (1Y)
0.77
Revenue Growth
-11.76%
EPS Growth
-146.55%
Country
Germany
Employees
553
Sector
Consumer Cyclical
Sector Strength
61
Industry
Auto - Parts

AB Dynamics Business Overview & Revenue Model

Company Description

AB Dynamics plc, through its various subsidiaries, is dedicated to the creation, development, production, and distribution of sophisticated testing and verification solutions. These solutions are vital for advanced driver assistance systems (ADAS), a...

AB Dynamics Earnings Call Summary

Earnings Call Date:Apr 13, 2026(Q2-2026)|% Change Since:-26.33%|Next Earnings Date:Nov 09, 2026
Earnings Call SentimentNeutral

The call balanced material near-term challenges—most notably a 16% revenue decline, a 29% drop in Testing Services driven by the underperformance of VadoTech in China and a GBP 16.8m impairment—with several strong fundamentals: recovered order intake (GBP 64m), a healthy net cash position (~GBP 39–40m), robust cash conversion (102%), maintained operating margin at 18.6%, a large simulation contract (EUR 9.7m), improved ROCE (21%), and an active innovation and M&A pipeline. Management reiterated a confidence in H2 recovery (55%–60% revenue bias), continued investment in R&D, and a focus on margin expansion to >20%. Given the material but largely isolated nature of the China/VadoTech issue alongside solid liquidity, margin resilience and orderbook recovery, the overall tone is cautiously constructive but acknowledges execution and timing risks.

Positive Updates

Order Intake Recovery and Forward Coverage
Order intake improved to GBP 64.0m in H1 FY26 (recovery from prior tariff-impacted period). Closing order book was GBP 47.0m (GBP 29.0m expected for H2), and combined with H1 revenue provides approximately 70% coverage of expected full-year 2026 revenue.

Negative Updates

Revenue and Earnings Decline
Group revenue declined 16% year-on-year in H1 FY26. Operating profit decreased 16% to GBP 9.1m and earnings per share fell 15% to 31.3p, reflecting timing delays in order intake and lower volumes in specific businesses.

Company Guidance

The management guidance was that FY‑26 will be second‑half weighted (approximately 55–60% of revenue in H2), with order intake recovering (H1 orders £64m, prior H2 orders were £44m), a closing order book of £47m (of which £29m is for H2) giving ~70% cover of expected full‑year revenue, and adjusted operating profit for FY‑26 expected to be in line with current expectations; H1 revenue was down 16% and operating profit fell 16% to £9.1m while operating margin was maintained at 18.6% (with a sustainable margin target of >20%), EPS was 31.3p (down 15%), effective tax rate 20%, rolling 12‑month cash conversion 102% (3‑year avg 105%), net cash ~£39–40m, interim dividend up 10%, a £16.8m non‑cash impairment of VadoTech was recorded, £2m of CapEx was invested in the period, ROCE rose to 21%, the group retains a £20m RCF and ~£55m debt capacity (c.2x EBITDA), and the medium‑term ambition remains to double revenue and triple operating profit with c.10% organic growth p.a. and continued disciplined M&A.

AB Dynamics Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

DE:6DY against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
GB:CTAGB:CTA66NeutralGBP 15.82M3.4220.83%―4.04%-25.71%
Sector *61Neutral$18.38B12.79-2.54%3.03%1.52%-15.83%
GB:MOTRGB:MOTR53NeutralGBP 116.62M21.5822.27%1.53%8.14%81.96%
GB:TRTGB:TRT51NeutralGBP 6.16M-58.70-1.47%―-16.65%-107.46%
GB:AURRGB:AURR43NeutralGBP 95.87M-16.96-29.78%―2.42%-18.45%

* Consumer Cyclical Sector Average

Performance Comparison

-50%0%50%100%DE:6DYGB:MOTRGB:TRTGB:CTAGB:AURRDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:6DY and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:6DYAB Dynamics9.40-5.08-35.10%
GB:MOTRMotorpoint Group plc141.00-12.34-8.05%
GB:TRTTransense Technologies PLC40.50-72.00-64.00%
GB:CTACT Automotive Group Plc22.50-10.50-31.82%
GB:AURRAurrigo International PLC100.0045.0081.82%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.